Advertisement

Topics

sterna biologicals GmbH & Co. KG Company Profile

16:09 EDT 18th August 2018 | BioPortfolio


News Articles [220 Associated News Articles listed on BioPortfolio]

German DNA Treatment Reduces Ulcerative Colitis Symptoms

Sterna Biologicals has obtained positive Phase IIa data for an ulcerative colitis treatment that uses DNA to inhibit inflammatory proteins. Sterna Biologicals, based in Marburg, Germany, has clinical ...

Sterna Sitting Pretty As Inflammatory Pipeline Shows Promise

In an interview with Scrip, Sterna Biologicals CEO Christian Pangratz says that the small German company has a number of...    

Sterna reports positive results in severe ulcerative colitis drug trial

sterna biological has reported positive results from the SECURE study, a Phase 2a trial in patients with moderate to severe ulcerative colitis treated with its GATA-3 specific DNAzyme formulation SB01...

sterna biologicals Reports Phase 2a Study Data Demonstrating Efficacy of Its GATA-3 Specific DNAzyme Formulation SB012 in Patients with Ulcerative Colitis

* Data presented at the 13th Congress of ECCO (European Crohn's and Colitis Organisation). * SB012 was safe and well tolerated and led to marked clinical and endos...

FDA approach to retrospectively naming biologicals

How the US Food and Drug Administration’s (FDA) is tackling retrospective naming of biologicals was an issue covered by Dr Kellie Taylor, Associate Director of the Office of Medication Error Prevent...

sterna's SB012 meets in Phase IIa data for UC

TGA proposes changes to biologicals regulations

Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA) announced on 20 April 2018 the release of proposed amendments to its biologicals regulations that are set to take effec...

Regulation of biologicals in Colombia

Since the introduction of Decree 1782 Colombia has been moving towards a new regulatory landscape for biologicals (productos bioterapéuticos) and similar biotherapeutic products (productos bioterape...

PubMed Articles [37 Associated PubMed Articles listed on BioPortfolio]

Nasal mites (Mesostigmata, Rhinonyssidae) in Sternidae (Aves: Charadriiformes) on the southern Coast of Brazil.

Six species of birds of the family Sternidae are often found on the southern coast of South America. Sterna trudeaui, S. hirundinacea, Thalasseus maximus, T. acuflavidus and Sternula superciliaris are...

Nasal mites (Mesostigmata, Rhinonyssidae) in Sternidae (Aves: Charadriiformes) on the southern Coast of Brazil.

Six species of birds of the family Sternidae are often found on the southern coast of South America. Sterna trudeaui, S. hirundinacea, Thalasseus maximus, T. acuflavidus and Sternula superciliaris are...

The analgesic potential of cytokine neutralization with biologicals.

Many acute and chronic inflammatory diseases, cancer and neuropathic disorders are accompanied by severe pain states reducing drastically the life quality of the patients. Biologicals which preferenti...

A large single hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents.

Large-scale studies of Drug Provocation Testing (DPT) or Rapid Drug Desensitization (RDD) for hypersensitivity to antineoplastics and biologicals are scarce and limited to a few institutions OBJECTIVE...

Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.

Biologicals targeting the interleukin (IL)-1β or IL-6 pathway are becoming prime choices for the treatment of children with systemic juvenile idiopathic arthritis (sJIA). Up to 1 in 3 sJIA children r...

Clinical Trials [314 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Companies [579 Associated Companies listed on BioPortfolio]

sterna biologicals GmbH & Co. KG

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Affinity Biologicals Inc

Affinity Biologicals Inc. (ABI) is now in it’s sixteenth year as a manufacturer of antibodies and antibody-related products for use in thrombosis and haemostasis research as well as medical diagnost...

More Information about "sterna biologicals GmbH & Co. KG" on BioPortfolio

We have published hundreds of sterna biologicals GmbH & Co. KG news stories on BioPortfolio along with dozens of sterna biologicals GmbH & Co. KG Clinical Trials and PubMed Articles about sterna biologicals GmbH & Co. KG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of sterna biologicals GmbH & Co. KG Companies in our database. You can also find out about relevant sterna biologicals GmbH & Co. KG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record